NAVIGATING COMPLIANT COLLABORATIONS BETWEEN PHARMA AND PATIENT SUPPORT GROUPS

As pharmaceutical and biotech companies continue to build advantageous, innovative relationships with advocacy organizations, ensuring compliant interaction during collaboration is a continued challenge, given the evolving regulatory and compliance frameworks. Advocacy executives are faced with multiple compliance concerns from off-label use of therapies and the promotion of products to navigating interest areas and defining the scope of patient groups. Ensuring advocacy professionals have a thorough understanding of compliant boundaries starts with proper education and relationships that are clearly defined.

• Working with legal/compliance teams to ensure compliance procedures
• Training to have compliant conversations when working with PAGs
• Defining compliant relationships and conversations
• Best practices in defining compliant patient group collaboration

Speaker:
Margaret Long
Vice President, Business Communications and Stakeholder Engagement
Astellas

Contact:

Brooke Akins | Division Director, Life Science Programs
+1 (312) 224-1693 | bakins@q1productions.com​